Hacker News
- Tirzepatide delivered up to 22.5% weight loss in obese or overweight adults https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-delivered-225-weight-loss-adults-obesity-or 21 comments
- Eli Lilly reports successful Phase 3 study for weight loss drug, with 63% of participants losing at least 20% of body weight on highest dose. https://investor.lilly.com/news-releases/news-release-details/lillys-tirzepatide-delivered-225-weight-loss-adults-obesity-or 158 comments science
Linking pages
- What to know about the new weight loss drug tirzepatide. Will it be affordable? https://www.nbcnews.com/news/rcna60422 809 comments
- Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims - The New York Times https://www.nytimes.com/2022/04/28/health/obesity-drug-eli-lilly-tirzepatide-wegovy.html 312 comments
- What to know about the new weight loss drug tirzepatide. Will it be affordable? https://www.nbcnews.com/health/health-news/weight-loss-drug-affordability-rcna60422 103 comments
- Obesity drug achieves average weight loss of 24 kg in clinical trial | New Scientist https://www.newscientist.com/article/2318588-obesity-drug-achieves-average-weight-loss-of-24-kg-in-clinical-trial/ 47 comments
Related searches:
Search whole site: site:investor.lilly.com
Search title: Tirzepatide delivered up to 22.5% weight loss in obese or overweight adults
See how to search.